The Cooper Companies, Inc.

The Cooper Companies, Inc. is a global medical device company that operates through two business segments: CooperVision and CooperSurgical. Headquartered in San Ramon, California, the company sells products in over 130 countries. CooperVision is a global manufacturer of contact lenses. It develops, manufactures, and markets a range of single-use, two-week, and monthly contact lenses made with advanced materials and optics, including silicone hydrogel Aquaform technology. These lenses address vision challenges such as astigmatism, presbyopia, and myopia, and include spherical, toric, and multifocal contact lenses. CooperVision also manufactures and markets myopia management products, such as the MiSight 1 day lens. The MiSight 1 day contact lens was approved by the United States Food and Drug Administration (FDA) in November 2019 for slowing the progression of myopia in children aged 8-12 at the initiation of treatment. It also received approval for use in China from the Chinese National Medical Products Administration (NMPA) in August 2021 and in Japan from the Japanese Ministry of Health, Labour and Welfare (MHLW) in August 2025. Additionally, CooperVision offers other specialty eyecare products like orthokeratology (ortho-k) and scleral lenses. CooperVision's main manufacturing and distribution facilities are located in Belgium, Costa Rica, Hungary, Puerto Rico, the United Kingdom, and the United States, with other smaller facilities globally. CooperSurgical provides a wide range of products and services focused on fertility and women's health.